Testing two versions of an experimental injection in healthy adult men
Part of Hormones & metabolism clinical trials.
This study checks whether two versions of an experimental medication (called GZR4) are the same in how they work in the body. It involves healthy adults and is a Phase 1 trial, meaning it's one of the first steps in testing a drug in humans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult male, aged 18 to 50 years.
- Weigh at least 110 lbs (50 kg) and have a body mass index (BMI) in the range of 18.5 to 24.0.
- Be willing to receive an injection under the skin (subcutaneous injection).
- If you could father a child, you must agree to use effective birth control and not donate sperm for up to 4 weeks after the dose.
- Have no significant allergies (like asthma, eczema, or severe food allergies) and no known allergy to the study drug or similar products.
- Be comfortable with needles and blood draws (no fear or difficulty with blood collection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
This study tests whether a change in the manufacturing process for GZR18 (an experimental injectable drug) affects how it works in the body. It may help determine if the new version is as safe and effective as the original.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
Hear when a new T2D trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.